Document is current

Article History

Received: 6 January 2023

Accepted: 26 February 2023

First Online: 17 March 2023

Declarations

:

: MK is supported by a postdoc fellowship from the German Academic Exchange Service (DAAD). CMT reports funding from NIH, Clinical trial support from InSightec Inc and serves as an advisor to Profound Medical ASK reports advisory board positions on hormone treatment for prostate cancer with Janssen and Myovant, and advisory board positions in the realm of prostate cancer with Bayer, Profound, Insightec, and Exelixis. ASK is also part of the Data Safety and Monitoring Committee with Bristol Myers Squibb and Advantage. QDT reports research funding from the American Cancer Society and Pfizer Global Medical Grants. APC reports research funding from the American Cancer Society and Pfizer Global Medical Grants. The remaining authors report no disclosures.

: An institutional review board waiver was obtained at Mass General Brigham (2016P000517).

: Not applicable.

: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval was granted by the Mass General Brigham Institutional Review Board (2016P000517).

: This is a de-identified data registry available to participating Commission of Cancer Institutions, and informed consent is not required.